- Home
- REKR vs CLYM Comparison
REKR vs CLYM Comparison
Compare REKR & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- CLYM
- Stock Information
- Founded
- REKR 2017
- CLYM 2018
- Country
- REKR United States
- CLYM United States
- Employees
- REKR N/A
- CLYM N/A
- Industry
- REKR Telecommunications Equipment
- CLYM
- Sector
- REKR Telecommunications
- CLYM
- Exchange
- REKR Nasdaq
- CLYM NYSE
- Market Cap
- REKR 115.1M
- CLYM 101.6M
- IPO Year
- REKR N/A
- CLYM 2021
- Fundamental
- Price
- REKR $0.84
- CLYM $1.21
- Analyst Decision
- REKR
- CLYM
- Analyst Count
- REKR 0
- CLYM 0
- Target Price
- REKR N/A
- CLYM N/A
- AVG Volume (30 Days)
- REKR 3.7M
- CLYM 168.2K
- Earning Date
- REKR 05-14-2025
- CLYM 05-14-2025
- Dividend Yield
- REKR N/A
- CLYM N/A
- EPS Growth
- REKR N/A
- CLYM N/A
- EPS
- REKR N/A
- CLYM N/A
- Revenue
- REKR $46,028,000.00
- CLYM N/A
- Revenue This Year
- REKR $42.85
- CLYM N/A
- Revenue Next Year
- REKR $36.19
- CLYM N/A
- P/E Ratio
- REKR N/A
- CLYM N/A
- Revenue Growth
- REKR 31.76
- CLYM N/A
- 52 Week Low
- REKR $0.78
- CLYM $1.18
- 52 Week High
- REKR $2.67
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- REKR 33.10
- CLYM N/A
- Support Level
- REKR $0.79
- CLYM N/A
- Resistance Level
- REKR $1.18
- CLYM N/A
- Average True Range (ATR)
- REKR 0.09
- CLYM 0.00
- MACD
- REKR 0.00
- CLYM 0.00
- Stochastic Oscillator
- REKR 11.25
- CLYM 0.00
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.